Muscular Dystrophy Research Today is a free monthly online journal that collates and summarizes the latest research about Muscular Dystrophy, including details on duchenne muscular dystrophy, symptoms, treatment.

Volume 4 (2008), Issue 2 (February)

1. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
   FASEB J, 22(2): 477-87. [Abstract] [Full-text]
2. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
   Proc Natl Acad Sci U S A, 105(7): 2646-51. [Abstract] [Full-text]
3. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
   Pediatr Res, 63(3): 268-73. [Abstract] [Full-text]
4. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
   Lab Invest, 88(3): 275-83. [Abstract] [Full-text]
5. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
   Neurology, 70(9): 677-85. [Abstract] [Full-text]

© 2005-2008 Muscular Dystrophy Research Today. All Rights Reserved.